Merus Labs International (Merus Labs International) Change In Receivables : $-7.92 Mil (TTM As of Mar. 2017)

View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Change In Receivables?

Merus Labs International's change in receivables for the quarter that ended in Mar. 2017 was $2.21 Mil. It means Merus Labs International's Accounts Receivable declined by $2.21 Mil from Dec. 2016 to Mar. 2017 .

Merus Labs International's change in receivables for the fiscal year that ended in Sep. 2016 was $-10.98 Mil. It means Merus Labs International's Accounts Receivable increased by $10.98 Mil from Sep. 2015 to Sep. 2016 .

Merus Labs International's Accounts Receivable for the quarter that ended in Mar. 2017 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Merus Labs International's Days Sales Outstanding for the three months ended in Mar. 2017 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Merus Labs International's liquidation value for the three months ended in Mar. 2017 was $-114.33 Mil.

Merus Labs International Change In Receivables Historical Data

The historical data trend for Merus Labs International's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Change In Receivables Chart

Merus Labs International Annual Data

Trend

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Change In Receivables

Get a 7-Day Free Trial

-2.16

-2.70

2.69

-7.64

-10.98

Merus Labs International Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Change In Receivables	Get a 7-Day Free Trial															-4.65	-2.97	-5.12	-2.04	2.21

Merus Labs International Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.92 Mil.

Merus Labs International (NAS:MSLI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Merus Labs International's Days Sales Outstanding for the quarter that ended in Mar. 2017 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	16.918	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Merus Labs International's accounts receivable are only considered to be worth 75% of book value:

Merus Labs International's liquidation value for the quarter that ended in Mar. 2017 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.979	-	121.077	+	0.75 * 0	+	0.5 * 11.531
=	-114.33

Merus Labs International Change In Receivables Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Merus Labs International (Merus Labs International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.meruslabs.com

Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines

From GuruFocus

Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems, Athabasca Minerals

By Gordon Pape Gordon Pape • 10-05-2015

Merus Labs International: A Pharma Stock With Growth Potential

By Gordon Pape Gordon Pape • 03-30-2015

Update on Merus Labs International, Athabasca Minerals Inc, Enghouse Systems Limited, WiLAN Inc.

By Gordon Pape Gordon Pape • 06-22-2015